HAS grading on some added benefit 51 ([30.4%] academia) vs 121 ([26.1%] industry) did not reach statistical significance ( P = .29).
← all excerpts
Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018.
1
0.2900
0.2900